Drawing on interviews with more than 80 scientists on two university campuses, we create a typology that offers insights into how transformations in the nature and locus of life science innovation influence academic careers and work practices. Our analyses suggest that a strong outcome of increased academic concern with research commercialisation is the appearance of new fault lines among faculty, between faculty and students, and even between scientists’ interests and those of their institutions. We argue that life science commercialisation is driven by a mix of new funding opportunities, changing institutional mandates for universities, and novel research technologies that bring basic research and product development into much closer cont...
In recent decades there has been a transformation in the field of science that has led to a blurrin...
In recent decades there has been a transformation in the field of science that has led to a blurrin...
Academic-industry partnerships in biopharmaceuticals have been commonly arranged through firms licen...
Drawing on interviews with more than 80 scientists on two university campuses, we create a typology ...
The realms of science and technology in the life sciences are converging through the commercializati...
Based on data from a survey of biological scientists at 125 American universities, this article expl...
Sur la base d’une enquête empirique auprès de chercheurs de deux campus universitaires, les auteurs ...
The central objective of the present paper is to examine how university bioscientists select their r...
The central objective of the present paper is to examine how university bioscientists select their r...
Given the need to compete for sponsored research funding, do university faculty believe they retain ...
Given the need to compete for sponsored research funding, do university faculty believe they retain ...
U.S. academic health centers are entering the bioscience and technology industries in ways that are ...
The rapid commercialization of applied genetics in the mtd-1970s, accompanied by a sudden rise in ac...
In recent decades there has been a transformation in the field of science that has led to a blurrin...
In recent decades there has been a transformation in the field of science that has led to a blurrin...
In recent decades there has been a transformation in the field of science that has led to a blurrin...
In recent decades there has been a transformation in the field of science that has led to a blurrin...
Academic-industry partnerships in biopharmaceuticals have been commonly arranged through firms licen...
Drawing on interviews with more than 80 scientists on two university campuses, we create a typology ...
The realms of science and technology in the life sciences are converging through the commercializati...
Based on data from a survey of biological scientists at 125 American universities, this article expl...
Sur la base d’une enquête empirique auprès de chercheurs de deux campus universitaires, les auteurs ...
The central objective of the present paper is to examine how university bioscientists select their r...
The central objective of the present paper is to examine how university bioscientists select their r...
Given the need to compete for sponsored research funding, do university faculty believe they retain ...
Given the need to compete for sponsored research funding, do university faculty believe they retain ...
U.S. academic health centers are entering the bioscience and technology industries in ways that are ...
The rapid commercialization of applied genetics in the mtd-1970s, accompanied by a sudden rise in ac...
In recent decades there has been a transformation in the field of science that has led to a blurrin...
In recent decades there has been a transformation in the field of science that has led to a blurrin...
In recent decades there has been a transformation in the field of science that has led to a blurrin...
In recent decades there has been a transformation in the field of science that has led to a blurrin...
Academic-industry partnerships in biopharmaceuticals have been commonly arranged through firms licen...